38 results
IDSA Aspergillosis Treatment
 • Invasive pulmonary aspergillosis (IPA)
 • CNS aspergillosis
 • Cardiac Aspergillus infection
 •
IDSA Aspergillosis ... Treatment • Invasive pulmonary ... Aspergillosis #Treatment #management ... #pharmacology # ... IDSA
Asthma Medications and Mechanism of Action

#Asthma #Medications #Drugs #Pulmonary #Pharmacology #Management #Treatment
Asthma Medications ... Action #Asthma #Medications ... #Drugs #Pulmonary ... #Pharmacology # ... Management #Treatment
POCUS Lung Algorithm for the Use of Ultrasound in the Evaluation of Dyspnea 

#Diagnosis #Management #CriticalCare
POCUS Lung Algorithm ... for the Use of Ultrasound ... #Diagnosis #Management ... Algorithm #Ddxof #Lung ... #Pulmonary
Doses of Antituberculosis Drugs for Adults and Children - IDSA
First-line drugs:
 • Isoniazid
 • Rifampin
 •
and Children - IDSA ... Tuberculosis #Drugs #Medications ... #management #pharmacology
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... Chronic Obstructive Lung ... LAMA: long-acting ... antagonist; LABA: long-acting ... #Management #Pulmonary
Asymptomatic Bacteriuria - IDSA Indications for Treatment
Healthy non-pregnant women - NO
Healthy pregnant women - YES
Functionally impaired
Bacteriuria - IDSA ... Indications for ... the community or long-term ... #Bacteriuria #IDSA ... #management #UTI
Massive Hemoptysis - Differential Diagnosis Framework and Management
Definition: 150-600 mL over 24 hours
Differential Diagnosis:
 • Tracheobronchial:
Alveolar Hemorrhage, Lung ... Primary Vascular: Pulmonary ... : 1) Indications ... Intubation 2) Bad Lung ... #pulmonary #criticalcare
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
Microbiologically Confirmed Pulmonary ... Tuberculosis - IDSA ... Therapy #regimens #medications ... #pharmacology # ... IDSA #Guidelines
Management of interstitial lung disease (ILD)-associated with systemic sclerosis (SSc)

Therapeutic indication: absolute decline in FVC >10%
Management of interstitial ... lung disease (ILD ... systemicsclerosis #SSc #pulmonary ... #indications #management
Pharmacological Treatment of Hepatorenal Syndrome (HRS)

Midodrine - Alpha agonist incr blood pressure incr renal perfusion pressure
Octreotide - Long-acting ... Syndrome #Nephrology #Management ... #Pharmacology # ... Medications #Treatment